Method for the treatment of anorexia nervosa

• US 20060014757A1
• Filed: 07/11/2005
• Published: 01/19/2006
• Est. Priority Date: 07/14/2004
• Status: Abandoned Application

• Current Assignee: Boehringer Ingelheim Pharmaceuticals Incorporated (C.H. Boehringer Sohn AG & Co. KG)
• Original Assignee: Boehringer Ingelheim Pharmaceuticals
• Inventors: Pyke, Robert
• Application Number:
  US11/178,716
• Publication Number:
  US 20060014757A1
• Time in Patent Office: Days
• US Class Current: 514/254.60
• CPC Class Codes: A61K 31/496 Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
• CPC Class Codes: A61P 1/14 Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
• CPC Class Codes: A61P 25/24 Antidepressants
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The invention relates to a method for the treatment of anorexia nervosa comprising the administration of a therapeutically effective amount of flibanserin.

Claims

1. ) A method for the treatment of anorexia nervosa comprising the administration of a therapeutically effective amount of flibanserin, or a pharmacologically acceptable acid addition salt thereof.

2. ) The method according claim 1, characterized in that flibanserin is administered in the form of a pharmaceutically acceptable acid addition salt selected from the salts formed by acids selected from succinic acid, hydrobromic acid, acetic acid, fumaric acid, maleic acid, methanesulphonic acid, lactic acid, phosphoric acid, hydrochloric acid, sulphuric acid, tartaric acid, citric acid, and mixtures thereof.

3. ) The method according to claim 1, characterized in that flibanserin is administered in a dosage range from between about 0.1 to about 400 mg per day.